Skip to the content
NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
  • About Us
    • Our Team
    • Our Labs
    • Why NeuroDex
  • Our Tech
    • ExoSORT™ Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
    • Pharmacodynamic Biomarkers
    • Cognilera® Panel for Trials
  • Applications
    • Alzheimer’s
    • Parkinson’s & Synucleinopathies
    • ALS & FTD
  • Resources
    • Learn
    • Alzheimer’s
    • Parkinson’s & Lewy Body
    • ALS & FTD
    • Methods
    • Regulatory & Trial Design
    • NeuroDex News
    • Biotech Blog
    • White Papers
    • NeuroDex Brochures
  • Contact Us

NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
HomePosted by NeuroDex Science Team
Digital illustration of the human brain highlighting protein aggregation, representing TDP-43 pathology in ALS and neurodegeneration
Biotech Blog

TDP-43 in ALS & Neurodegeneration: Key Insights

NeuroDex Science Team
September 25, 2025
Scientist examining samples under a microscope in a laboratory, representing ALS drug development research
Biotech Blog

ALS Drug Development: A Comparative Analysis of Oral, Antioxidant, & Gene-Targeted Approaches

NeuroDex Science Team
September 17, 2025
Scientist in a lab handling a sample with gloved hands, representing research into biomarkers for ALS diagnosis and monitoring
Biotech Blog

The Role of Biomarkers in ALS Diagnosis & Monitoring

NeuroDex Science Team
September 10, 2025
Exploring Today’s ALS Treatment Options & Emerging Research
Biotech Blog

Exploring Today’s ALS Treatment Options & Emerging Research

NeuroDex Science Team
September 3, 2025
Discover how our Biomarker Discovery Services at NeuroDex utilize advanced technologies to identify and validate novel biomarkers, accelerating your research and development processes.
Biotech Blog

Biomarker Discovery Services for CNS Drug Development

NeuroDex Science Team
July 26, 2024
Biomarkers as Game-Changers in Neurodegenerative Disease Diagnostics
Biotech Blog

Biomarkers as Game-Changers in Neurodegenerative Disease Diagnostics

NeuroDex Science Team
April 11, 2024
the Battle Against Parkinson's Disease
Biotech Blog

Pioneering Biotech Efforts in the Battle Against Parkinson’s Disease

NeuroDex Science Team
February 8, 2024
Revolutionary 3D-Printed Brain Tissue
Biotech Blog

Revolutionary 3D-Printed Brain Tissue Offers New Insights into Neuroscience

NeuroDex Science Team
February 5, 2024
Neurodegenerative Disease Market
Biotech Blog

Neurodegenerative Disease Market Poised for Remarkable Growth, Projected to Reach USD 69.8 Billion by 2030

NeuroDex Science Team
January 23, 2024
China Approves Leqembi
Biotech Blog

China Approves Leqembi® for Alzheimer’s Treatment: A New Hope in the Fight Against Cognitive Decline

NeuroDex Science Team
January 10, 2024

Posts pagination

1 2 3

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • info@neurodex.co
Information
  • Terms & Conditions
  • Privacy Policy
  • NeuroDex FAQ
Resources
  • Explanation Material
  • NeuroDex News
  • Blog
Back to top Drag
  • About Us
    • Our Team
    • Our Labs
    • Why NeuroDex
  • Our Tech
    • ExoSORT™ Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
    • Pharmacodynamic Biomarkers
    • Cognilera® Panel for Trials
  • Applications
    • Alzheimer’s
    • Parkinson’s & Synucleinopathies
    • ALS & FTD
  • Resources
    • Learn
    • Alzheimer’s
    • Parkinson’s & Lewy Body
    • ALS & FTD
    • Methods
    • Regulatory & Trial Design
    • NeuroDex News
    • Biotech Blog
    • White Papers
    • NeuroDex Brochures
  • Contact Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}